المنشورات
The total number of his scientific works is 654 (publications and abstracts), he has written 6 books and 13 chapters in books. His Hirsch index is 42.
Since 2002, he has been an official reviewer of the following scientific journals: Journal of Urology, European Urology, British Journal of Urology International, Lancet, Cancer Detection and Prevention, Urologia Internationalis, Brazilian Journal of Urology, Prostate Cancer and Prostatic Diseases, Medical Science Monitor (International Medical Journal for Experimental and Clinical Research). Since 2004 he has been a member of the steering committee of SIEUN (Italian Society of Urological and Nephrological Ultrasound), in 2011 he became Vice-President, and since 2006 he has been a member of the Scientific Committee of SIURO (Italian Society of Oncological Urology). Since January 2016, he has been a full member of the Board of ESUI (European Society of Urological Imaging).
أحدث المنشورات
Dynamic Gadolinium enhanced magnetic resonance imaging in staging of superficial bladder cancer
J Urol 155: 1594-1599, 1996.
Scattoni V, Da Pozzo L, Colombo R, Nava L, Rigatti P, De Cobelli F, Vanzulli A, Del Maschio A
قراءة المزيد
Percent of free serum prostate-specific antigen and hystological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia
Eur Urol 36:621-630, 1999
Scattoni V, Raber M, Montorsi F, Da Pozzo L, Brausi M, Calori G, Freschi M, Rigatti P
قراءة المزيد
Prostatic transrectal ultrasound (TRUS) guided biopsy schemes and TRUS prostatic lesion-guided biopsies
Eur Urol Suppl 1(6): 28-34, 2002.
Scattoni V, Zlotta AR, Nava L, Roscigno M, Montorsi F, Rigatti P
قراءة المزيد
Biopsy of the vesico-urethral anastomosis after radical prostatectomy: when and how
Eur Urol Suppl 1(6): 89-95, 2002.
Scattoni V, Roscigno M, Raber M, Consonni P, Da Pozzo L, Rigatti P
قراءة المزيد
Multiple vesico-urethral biopsies following a radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage
Eur Urol 44:407-414, 2003.
Scattoni V, Roscigno M, Raber M, Montorsi F, Da Pozzo L, Guazzoni G, Freschi M, Rigatti P
قراءة المزيد
Diagnosis of local recurrence after radical prostatectomy.
BJU Int 93(5), 680-688, 2004
Scattoni V, Montorsi F, Picchio M, Roscigno M, Salonia A, Rigatti P, F. Fazio
قراءة المزيد
Predictors of prostate cancer after initial diagnosis of atypical small acinar proliferation at 10 to 12 core biopsies.
Urology 66: 1043-1047, 2005.
Scattoni V, Roscigno M, Freschi M, Briganti A, Fantini GV, Bertini R, Salonia A, Montorsi F, Rigatti P
قراءة المزيد
Pathological changes of high-grade prostatic intraepithelial neoplasia and prostate cancer after monotherapy with bicalutamide 150 mg
BJU Int. Jul;98(1):54-8. 2006
Scattoni V, Montironi R, Mazzucchelli R, Freschi M, Nava L, Losa A, Terrone C, Scarpa RM, Montorsi F, Pappagallo G, Rigatti P.
قراءة المزيد
Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy
Eur Urol; 49(6):1019-26, 2006.
Briganti A, Chun FK, Salonia A, Zanni G, Scattoni V, Valiquette L, Rigatti P,Montorsi F, Karakiewicz PI
قراءة المزيد
Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy
Eur Urol; 52(2):423- 9, 2007
Scattoni V, Picchio M, Suardi N, Messa C, Freschi M, Roscigno M, Da Pozzo L, Bocciardi A, Rigatti P, Fazio F
قراءة المزيد
Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature
Eur Urol; 52(5):1309-22, 2007
Scattoni V, Zlotta A, Montironi R, Schulman C, Rigatti P, Montorsi F
قراءة المزيد
Initial extended transrectal prostate biopsy--are more prostate cancers detected with 18 cores than with 12 cores?
J Urol; 179(4):1327-31, 2008.
Scattoni V, Roscigno M, Raber M, Dehò F, Maga T, Zanoni M, Riva M, Sangalli M, Nava L, Mazzoccoli B, Freschi M, Guazzoni G, Rigatti P, Montorsi F.
قراءة المزيد
Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
Cancer; 113(10):2695-703, 2008
Walz J, Haese A, Scattoni V, Steuber T, Chun FK, Briganti A, Montorsi F, Graefen M, Huland H, Karakiewicz PI
قراءة المزيد
Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy.
Eur Urol; 57(1):1-8, 2010
Scattoni V, Raber M, Abdollah F, Roscigno M, Dehò F, Angiolilli D, Maccagnano C, Gallina A, Capitanio U, Freschi M, Doglioni C, Rigatti P, Montorsi F
قراءة المزيد
Is extended and saturation biopsy necessary?
Int J Urol; 17(5):432-47, 2010
Scattoni V, Maccagnano C, Zanni G, Angiolilli D, Raber M, Roscigno M, Rigatti P, Montorsi F
قراءة المزيد